Search Clinical Trials
597,593 trials
ID
Status
Phase
Title
Sponsor
NCT07754045
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutide Plus Placebo in Older Obese AdultsLumos PharmaNot Yet RecruitingPhase 2
NCT07754045Not Yet Recruiting
Phase 2
Evaluating the Efficacy and Safety of LUM-201 Plus Semaglutide Versus Semaglutid...Lumos Pharma
NCT07756385
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs. Centurion)University Hospital Sveti DuhRecruitingNot Applicable
NCT07756385Recruiting
Not Applicable
Comparison of Two Phacoemulsification Systems in Cataract Surgery (UNITY VCS vs....University Hospital Sveti...
NCT07756268
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisCSPC Baike (Shandong) Bio-Pharmaceutical Co., Ltd.Not Yet RecruitingPhase 1
NCT07756268Not Yet Recruiting
Phase 1
Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple SclerosisCSPC Baike (Shandong) Bio...
NCT07755579
Effect of Autologous Ear Cartilage Micrografting in Knee OsteoarthritisOrthosera Kft.Active Not RecruitingNot Applicable
NCT07755579Active Not Recruiting
Not Applicable
Effect of Autologous Ear Cartilage Micrografting in Knee OsteoarthritisOrthosera Kft.
NCT07754994
Medication Self-Management Technology for Older AdultsArizona State UniversityNot Yet RecruitingNot Applicable
NCT07754994Not Yet Recruiting
Not Applicable
Medication Self-Management Technology for Older AdultsArizona State University
NCT07754825
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Ischemic StrokeShanghai Pharmaceuticals Holding Co., LtdNot Yet RecruitingPhase 2
NCT07754825Not Yet Recruiting
Phase 2
A Phase II Clinical Study of LT3001 for Injection in the Treatment of Acute Isch...Shanghai Pharmaceuticals...
NCT07754084
Comprehensive Clinical Prediction Rule for Acute Heart FailureChinese University of Hong KongNot Yet Recruiting
NCT07754084Not Yet Recruiting
—
Comprehensive Clinical Prediction Rule for Acute Heart FailureChinese University of Hon...
NCT07755527
Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement - Open TrialHenry Ford Health SystemNot Yet RecruitingNot Applicable
NCT07755527Not Yet Recruiting
Not Applicable
Healing After Injury to Reduce Opioid Use and Pain Through Preventive Engagement...Henry Ford Health System
NCT07756567
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for PsychosisNational Institute of Mental Health (NIMH)Not Yet RecruitingNot Applicable
NCT07756567Not Yet Recruiting
Not Applicable
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Cl...National Institute of Men...
NCT07756060
Creatine Supplementation in Pediatric Brain InjurySpaulding Rehabilitation HospitalNot Yet RecruitingNot Applicable
NCT07756060Not Yet Recruiting
Not Applicable
Creatine Supplementation in Pediatric Brain InjurySpaulding Rehabilitation...
NCT07755800
Impact of an Arginine-containing Toothpaste on the Subgingival Microbiota in Patients in Supportive Periodontal CareSukirth M Ganesan, BDS, PhDNot Yet RecruitingNot Applicable
NCT07755800Not Yet Recruiting
Not Applicable
Impact of an Arginine-containing Toothpaste on the Subgingival Microbiota in Pat...Sukirth M Ganesan, BDS, P...
NCT07754760
Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availability Following a Standard-protein Breakfast in Older AdultsLeeds Beckett UniversityCompletedNot Applicable
NCT07754760Completed
Not Applicable
Essential Amino Acid Supplementation Enhances Post-prandial Amino Acid Availabil...Leeds Beckett University
NCT07754721
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study of Multidimensional Interventions and Health ImpactsHualien Tzu Chi General HospitalRecruitingNot Applicable
NCT07754721Recruiting
Not Applicable
Comprehensive Management Strategies for Gastroesophageal Reflux Disease: A Study...Hualien Tzu Chi General H...
NCT07756034
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in CancerBlood Cancer UnitedRecruiting
NCT07756034Recruiting
—
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platfor...Blood Cancer United
NCT07754552
DEVELOPMENT AND EVALUATION OF THE EFFECTIVENESS OF THE SMART-HAND PROTOCOL FOR HAND REHABILITATION IN PATIENTS WITH RHEUMATOID ARTHRITISIstanbul University - CerrahpasaNot Yet RecruitingNot Applicable
NCT07754552Not Yet Recruiting
Not Applicable
DEVELOPMENT AND EVALUATION OF THE EFFECTIVENESS OF THE SMART-HAND PROTOCOL FOR H...Istanbul University - Cer...
NCT07754734
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter MethylationDongguan People's HospitalNot Yet RecruitingPhase 2
NCT07754734Not Yet Recruiting
Phase 2
STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With M...Dongguan People's Hospita...
NCT07754071
Clinical Validation of an Artificial Intelligence System for De-termining Fetal Lie and Position in 3rd TrimesterCopenhagen Academy for Medical Education and SimulationRecruiting
NCT07754071Recruiting
—
Clinical Validation of an Artificial Intelligence System for De-termining Fetal...Copenhagen Academy for Me...
NCT07755553
Effect of a Mushroom Extract-Containing Topical Cosmetic Formulation During Breast RadiotherapyAITEX Centro Investigación E InnovaciónCompletedNot Applicable
NCT07755553Completed
Not Applicable
Effect of a Mushroom Extract-Containing Topical Cosmetic Formulation During Brea...AITEX Centro Investigació...
NCT07756177Active Not Recruiting
—
Guangzhou Preterm and Term Birth Cohort StudySun Yat-sen University
NCT07755020
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial HospitalRecruiting
NCT07755020Recruiting
—
Nitride-Based Raman Biochip for Lung Cancer Diagnosis and MonitoringFar Eastern Memorial Hosp...
Result Breakdown
Not yet recruiting11 (55%)
Recruiting5 (25%)
Active, not recruiting2 (10%)
Completed2 (10%)
not_applicable11 (55%)
Not Specified5 (25%)
Phase 23 (15%)
Phase 11 (5%)